Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Characterizing a perfusion-based periventricular small vessel region of interest.

Dolui S, Tisdall D, Vidorreta M, Jacobs DR Jr, Nasrallah IM, Bryan RN, Wolk DA, Detre JA.

Neuroimage Clin. 2019 Jun 12;23:101897. doi: 10.1016/j.nicl.2019.101897. [Epub ahead of print]

2.

A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data.

Li H, Habes M, Wolk DA, Fan Y; Alzheimer's Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle Study of Aging.

Alzheimers Dement. 2019 Jun 11. pii: S1552-5260(19)30086-X. doi: 10.1016/j.jalz.2019.02.007. [Epub ahead of print]

PMID:
31201098
3.

Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.

Phillips JS, Da Re F, Irwin DJ, McMillan CT, Vaishnavi SN, Xie SX, Lee EB, Cook PA, Gee JC, Shaw LM, Trojanowski JQ, Wolk DA, Grossman M.

Brain. 2019 Jun 1;142(6):1701-1722. doi: 10.1093/brain/awz091.

PMID:
31135048
4.

Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease.

Xie L, Wisse LEM, Pluta J, de Flores R, Piskin V, Manjón JV, Wang H, Das SR, Ding SL, Wolk DA, Yushkevich PA; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2019 Aug 15;40(12):3431-3451. doi: 10.1002/hbm.24607. Epub 2019 Apr 29.

PMID:
31034738
5.

Characterizing Anatomical Variability And Alzheimer's Disease Related Cortical Thinning in the Medial Temporal Lobe Using Graph-Based Groupwise Registration And Point Set Geodesic Shooting.

Xie L, Wisse LEM, Das SR, Ittyerah R, Wang J, Wolk DA, Yushkevich PA.

Shape Med Imaging (2018). 2018 Sep;11167:28-37. doi: 10.1007/978-3-030-04747-4_3. Epub 2018 Nov 23.

6.

TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.

Tropea TF, Mak J, Guo MH, Xie SX, Suh E, Rick J, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Trojanowski JQ, Van Deerlin V, Chen-Plotkin AS.

Ann Neurol. 2019 Jun;85(6):801-811. doi: 10.1002/ana.25486.

PMID:
30973966
7.

Fractionating the Rey Auditory Verbal Learning Test: Distinct roles of large-scale cortical networks in prodromal Alzheimer's disease.

Putcha D, Brickhouse M, Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.

Neuropsychologia. 2019 Jun;129:83-92. doi: 10.1016/j.neuropsychologia.2019.03.015. Epub 2019 Mar 28.

PMID:
30930301
8.

Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia.

Giannini LAA, Xie SX, McMillan CT, Liang M, Williams A, Jester C, Rascovsky K, Wolk DA, Ash S, Lee EB, Trojanowski JQ, Grossman M, Irwin DJ.

Ann Neurol. 2019 May;85(5):630-643. doi: 10.1002/ana.25465. Epub 2019 Mar 28.

PMID:
30851133
9.

Associative memory for conceptually unitized word pairs in mild cognitive impairment is related to the volume of the perirhinal cortex.

Delhaye E, Mechanic-Hamilton D, Saad L, Das SR, Wisse LEM, Yushkevich PA, Wolk DA, Bastin C.

Hippocampus. 2019 Jul;29(7):630-638. doi: 10.1002/hipo.23063. Epub 2018 Dec 26.

10.

Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.

Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Branch Coslett H, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VM, Grossman M, Trojanowski JQ, Irwin DJ.

Ann Neurol. 2019 Feb;85(2):259-271. doi: 10.1002/ana.25392. Epub 2019 Jan 7.

11.

Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.

Sandelius Å, Portelius E, Källén Å, Zetterberg H, Rot U, Olsson B, Toledo JB, Shaw LM, Lee VMY, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk DA, McCluskey L, Elman L, Kostanjevecki V, Vandijck M, McBride J, Trojanowski JQ, Blennow K.

Alzheimers Dement. 2019 Jan;15(1):55-64. doi: 10.1016/j.jalz.2018.08.006. Epub 2018 Oct 12.

12.

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, Fox NC, Sanchez-Valle R, Grau-Rivera O, Gelpi E, Seelaar H, Papma JM, van Swieten JC, Hodges JR, Leyton CE, Piguet O, Rogalski EJ, Mesulam MM, Koric L, Nora K, Pariente J, Dickerson B, Mackenzie IR, Hsiung GR, Belliard S, Irwin DJ, Wolk DA, Grossman M, Jones M, Harris J, Mann D, Snowden JS, Chrem-Mendez P, Calandri IL, Amengual AA, Miguet-Alfonsi C, Magnin E, Magnani G, Santangelo R, Deramecourt V, Pasquier F, Mattsson N, Nilsson C, Hansson O, Keith J, Masellis M, Black SE, Matías-Guiu JA, Cabrera-Martin MN, Paquet C, Dumurgier J, Teichmann M, Sarazin M, Bottlaender M, Dubois B, Rowe CC, Villemagne VL, Vandenberghe R, Granadillo E, Teng E, Mendez M, Meyer PT, Frings L, Lleó A, Blesa R, Fortea J, Seo SW, Diehl-Schmid J, Grimmer T, Frederiksen KS, Sánchez-Juan P, Chételat G, Jansen W, Bouchard RW, Laforce RJ, Visser PJ, Ossenkoppele R.

Ann Neurol. 2018 Nov;84(5):729-740. doi: 10.1002/ana.25333.

13.

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.

Gangishetti U, Christina Howell J, Perrin RJ, Louneva N, Watts KD, Kollhoff A, Grossman M, Wolk DA, Shaw LM, Morris JC, Trojanowski JQ, Fagan AM, Arnold SE, Hu WT.

Alzheimers Res Ther. 2018 Sep 25;10(1):98. doi: 10.1186/s13195-018-0426-3.

14.

Task-enhanced arterial spin labeled perfusion MRI predicts longitudinal neurodegeneration in mild cognitive impairment.

Xie L, Das SR, Pilania A, Daffner M, Stockbower GE, Dolui S, Yushkevich PA, Detre JA, Wolk DA.

Hippocampus. 2019 Jan;29(1):26-36. doi: 10.1002/hipo.23026. Epub 2018 Nov 6.

15.

Alzheimer's genetic risk is reduced in primary age-related tauopathy: a potential model of resistance?

McMillan CT, Lee EB, Jefferson-George K, Naj A, Van Deerlin VM, Trojanowski JQ, Wolk DA.

Ann Clin Transl Neurol. 2018 Jun 19;5(8):927-934. doi: 10.1002/acn3.581. eCollection 2018 Aug.

16.

White matter lesions: Spatial heterogeneity, links to risk factors, cognition, genetics, and atrophy.

Habes M, Sotiras A, Erus G, Toledo JB, Janowitz D, Wolk DA, Shou H, Bryan NR, Doshi J, Völzke H, Schminke U, Hoffmann W, Resnick SM, Grabe HJ, Davatzikos C.

Neurology. 2018 Sep 4;91(10):e964-e975. doi: 10.1212/WNL.0000000000006116. Epub 2018 Aug 3.

PMID:
30076276
17.

Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison.

Bezdicek O, Červenková M, Moore TM, Stepankova Georgi H, Sulc Z, Wolk DA, Weintraub DA, Moberg PJ, Jech R, Kopecek M, Roalf DR.

Assessment. 2018 Jun 1:1073191118778896. doi: 10.1177/1073191118778896. [Epub ahead of print]

PMID:
29929376
18.

Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease.

Barnes J, Bartlett JW, Wolk DA, van der Flier WM, Frost C.

J Alzheimers Dis. 2018;64(2):631-642. doi: 10.3233/JAD-170841.

19.

Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.

Wolk DA, Sadowsky C, Safirstein B, Rinne JO, Duara R, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, Albert M, Fleisher A, Loughlin P, Triau E, Frey K, Høgh P, Bozoki A, Bullock R, Salmon E, Farrar G, Buckley CJ, Zanette M, Sherwin PF, Cherubini A, Inglis F.

JAMA Neurol. 2018 Sep 1;75(9):1114-1123. doi: 10.1001/jamaneurol.2018.0894.

20.

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment.

Racine AM, Brickhouse M, Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement (Amst). 2018 Mar 17;10:301-310. doi: 10.1016/j.dadm.2018.02.007. eCollection 2018.

21.

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology.

Portelius E, Olsson B, Höglund K, Cullen NC, Kvartsberg H, Andreasson U, Zetterberg H, Sandelius Å, Shaw LM, Lee VMY, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk DA, McCluskey L, Elman L, McBride J, Toledo JB, Trojanowski JQ, Blennow K.

Acta Neuropathol. 2018 Sep;136(3):363-376. doi: 10.1007/s00401-018-1851-x. Epub 2018 Apr 26.

22.

The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.

Knopman DS, Haeberlein SB, Carrillo MC, Hendrix JA, Kerchner G, Margolin R, Maruff P, Miller DS, Tong G, Tome MB, Murray ME, Nelson PT, Sano M, Mattsson N, Sultzer DL, Montine TJ, Jack CR Jr, Kolb H, Petersen RC, Vemuri P, Canniere MZ, Schneider JA, Resnick SM, Romano G, van Harten AC, Wolk DA, Bain LJ, Siemers E.

Alzheimers Dement. 2018 Apr;14(4):563-575. doi: 10.1016/j.jalz.2018.03.002. Review.

PMID:
29653607
23.

Regional tract-specific white matter hyperintensities are associated with patterns to aging-related brain atrophy via vascular risk factors, but also independently.

Habes M, Erus G, Toledo JB, Bryan N, Janowitz D, Doshi J, Völzke H, Schminke U, Hoffmann W, Grabe HJ, Wolk DA, Davatzikos C.

Alzheimers Dement (Amst). 2018 Mar 5;10:278-284. doi: 10.1016/j.dadm.2018.02.002. eCollection 2018.

24.

Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?

Xie L, Shinohara RT, Ittyerah R, Kuijf HJ, Pluta JB, Blom K, Kooistra M, Reijmer YD, Koek HL, Zwanenburg JJM, Wang H, Luijten PR, Geerlings MI, Das SR, Biessels GJ, Wolk DA, Yushkevich PA, Wisse LEM.

J Alzheimers Dis. 2018;63(1):217-225. doi: 10.3233/JAD-170932.

25.

Older Adult Normative Data for the Sniffin' Sticks Odor Identification Test.

Vickers KL, Breslin K, Roalf DR, Kamath V, Xie SX, Moberg PJ, Wolk DA, Mechanic-Hamilton D.

Arch Clin Neuropsychol. 2019 Mar 1;34(2):254-258. doi: 10.1093/arclin/acy021.

26.

Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease.

Shi M, Tang L, Toledo JB, Ginghina C, Wang H, Aro P, Jensen PH, Weintraub D, Chen-Plotkin AS, Irwin DJ, Grossman M, McCluskey L, Elman LB, Wolk DA, Lee EB, Shaw LM, Trojanowski JQ, Zhang J.

Alzheimers Dement. 2018 Aug;14(8):1052-1062. doi: 10.1016/j.jalz.2018.02.015. Epub 2018 Mar 28.

PMID:
29604263
27.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleo A, Molinuevo JL, Jagust WJ, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimalla R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon MJ, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R.

Alzheimers Dement. 2018 Jul;14(7):913-924. doi: 10.1016/j.jalz.2018.02.009. Epub 2018 Mar 28.

PMID:
29601787
28.

Characterizing the human hippocampus in aging and Alzheimer's disease using a computational atlas derived from ex vivo MRI and histology.

Adler DH, Wisse LEM, Ittyerah R, Pluta JB, Ding SL, Xie L, Wang J, Kadivar S, Robinson JL, Schuck T, Trojanowski JQ, Grossman M, Detre JA, Elliott MA, Toledo JB, Liu W, Pickup S, Miller MI, Das SR, Wolk DA, Yushkevich PA.

Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):4252-4257. doi: 10.1073/pnas.1801093115. Epub 2018 Mar 28.

29.

A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.

Lleó A, Irwin DJ, Illán-Gala I, McMillan CT, Wolk DA, Lee EB, Van Deerlin VM, Shaw LM, Trojanowski JQ, Grossman M.

JAMA Neurol. 2018 Jun 1;75(6):738-745. doi: 10.1001/jamaneurol.2018.0118.

30.

Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.

Das SR, Xie L, Wisse LEM, Ittyerah R, Tustison NJ, Dickerson BC, Yushkevich PA, Wolk DA; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2018 Jun;66:49-58. doi: 10.1016/j.neurobiolaging.2018.01.024. Epub 2018 Feb 9.

31.

The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.

Trombetta BA, Carlyle BC, Koenig AM, Shaw LM, Trojanowski JQ, Wolk DA, Locascio JJ, Arnold SE.

PLoS One. 2018 Mar 5;13(3):e0193707. doi: 10.1371/journal.pone.0193707. eCollection 2018.

32.

Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration.

Wisse LEM, Das SR, Davatzikos C, Dickerson BC, Xie SX, Yushkevich PA, Wolk DA.

Neuroimage Clin. 2018 Feb 8;18:407-412. doi: 10.1016/j.nicl.2018.02.008. eCollection 2018.

33.

CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.

Irwin DJ, Xie SX, Coughlin D, Nevler N, Akhtar RS, McMillan CT, Lee EB, Wolk DA, Weintraub D, Chen-Plotkin A, Duda JE, Spindler M, Siderowf A, Hurtig HI, Shaw LM, Grossman M, Trojanowski JQ.

Neurology. 2018 Mar 20;90(12):e1038-e1046. doi: 10.1212/WNL.0000000000005166. Epub 2018 Feb 21.

34.

Early Tau Burden Correlates with Higher Rate of Atrophy in Transentorhinal Cortex.

Xie L, Das SR, Wisse LEM, Ittyerah R, Yushkevich PA, Wolk DA; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2018;62(1):85-92. doi: 10.3233/JAD-170945.

35.

Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease.

Phillips JS, Da Re F, Dratch L, Xie SX, Irwin DJ, McMillan CT, Vaishnavi SN, Ferrarese C, Lee EB, Shaw LM, Trojanowski JQ, Wolk DA, Grossman M.

Neurobiol Aging. 2018 Mar;63:75-87. doi: 10.1016/j.neurobiolaging.2017.11.008. Epub 2017 Nov 21.

36.

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H.

JAMA Psychiatry. 2018 Jan 1;75(1):84-95. doi: 10.1001/jamapsychiatry.2017.3391. Erratum in: JAMA Psychiatry. 2018 Mar 1;75(3):303.

37.

Mapping the structural and functional network architecture of the medial temporal lobe using 7T MRI.

Shah P, Bassett DS, Wisse LEM, Detre JA, Stein JM, Yushkevich PA, Shinohara RT, Pluta JB, Valenciano E, Daffner M, Wolk DA, Elliott MA, Litt B, Davis KA, Das SR.

Hum Brain Mapp. 2018 Feb;39(2):851-865. doi: 10.1002/hbm.23887. Epub 2017 Nov 20.

38.

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.

Sheinerman KS, Toledo JB, Tsivinsky VG, Irwin D, Grossman M, Weintraub D, Hurtig HI, Chen-Plotkin A, Wolk DA, McCluskey LF, Elman LB, Trojanowski JQ, Umansky SR.

Alzheimers Res Ther. 2017 Nov 9;9(1):89. doi: 10.1186/s13195-017-0316-0.

39.

Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease.

Phillips JS, Das SR, McMillan CT, Irwin DJ, Roll EE, Da Re F, Nasrallah IM, Wolk DA, Grossman M.

Hum Brain Mapp. 2018 Feb;39(2):691-708. doi: 10.1002/hbm.23874. Epub 2017 Nov 6.

40.

Whole-brain background-suppressed pCASL MRI with 1D-accelerated 3D RARE Stack-Of-Spirals readout.

Vidorreta M, Wang Z, Chang YV, Wolk DA, Fernández-Seara MA, Detre JA.

PLoS One. 2017 Aug 24;12(8):e0183762. doi: 10.1371/journal.pone.0183762. eCollection 2017.

41.

Accounting for the Confound of Meninges in Segmenting Entorhinal and Perirhinal Cortices in T1-Weighted MRI.

Xie L, Wisse LEM, Das SR, Wang H, Wolk DA, Manjón JV, Yushkevich PA.

Med Image Comput Comput Assist Interv. 2016 Oct;9901:564-571. doi: 10.1007/978-3-319-46723-8_65. Epub 2016 Oct 2.

42.

18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease.

Nasrallah IM, Chen YJ, Hsieh MK, Phillips JS, Ternes K, Stockbower GE, Sheline Y, McMillan CT, Grossman M, Wolk DA.

J Nucl Med. 2018 Feb;59(2):299-306. doi: 10.2967/jnumed.117.194282. Epub 2017 Jul 26. Erratum in: J Nucl Med. 2019 May;60(5):709.

43.

Comparison of PASL, PCASL, and background-suppressed 3D PCASL in mild cognitive impairment.

Dolui S, Vidorreta M, Wang Z, Nasrallah IM, Alavi A, Wolk DA, Detre JA.

Hum Brain Mapp. 2017 Oct;38(10):5260-5273. doi: 10.1002/hbm.23732. Epub 2017 Jul 24.

44.

Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.

Irwin DJ, Lleó A, Xie SX, McMillan CT, Wolk DA, Lee EB, Van Deerlin VM, Shaw LM, Trojanowski JQ, Grossman M.

Ann Neurol. 2017 Aug;82(2):247-258. doi: 10.1002/ana.24996. Epub 2017 Aug 19.

45.

A protocol for manual segmentation of medial temporal lobe subregions in 7 Tesla MRI.

Berron D, Vieweg P, Hochkeppler A, Pluta JB, Ding SL, Maass A, Luther A, Xie L, Das SR, Wolk DA, Wolbers T, Yushkevich PA, Düzel E, Wisse LEM.

Neuroimage Clin. 2017 May 26;15:466-482. doi: 10.1016/j.nicl.2017.05.022. eCollection 2017.

46.

Effects of cognitive reserve depend on executive and semantic demands of the task.

Darby RR, Brickhouse M, Wolk DA, Dickerson BC; Alzheimer’s Disease Neuroimaging Initiative.

J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):794-802. doi: 10.1136/jnnp-2017-315719. Epub 2017 Jun 19.

47.

Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.

Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):107-113. doi: 10.1097/WAD.0000000000000202.

48.

Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.

Giannini LAA, Irwin DJ, McMillan CT, Ash S, Rascovsky K, Wolk DA, Van Deerlin VM, Lee EB, Trojanowski JQ, Grossman M.

Neurology. 2017 Jun 13;88(24):2276-2284. doi: 10.1212/WNL.0000000000004034. Epub 2017 May 17.

49.

Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases.

Kovacs GG, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA, Irwin DJ, Weintraub D, Kim CF, Schuck T, Yousef A, Wagner ST, Suh E, Van Deerlin VM, Lee VM, Trojanowski JQ.

J Neuropathol Exp Neurol. 2017 Apr 1;76(4):270-288. doi: 10.1093/jnen/nlx007.

50.

Cognitive decline associated with pathological burden in primary age-related tauopathy.

Jefferson-George KS, Wolk DA, Lee EB, McMillan CT.

Alzheimers Dement. 2017 Sep;13(9):1048-1053. doi: 10.1016/j.jalz.2017.01.028. Epub 2017 Mar 16.

Supplemental Content

Support Center